Netherlands
# |
Name |
Share Price |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 39.01 |
Jan. 14, 2025 | USD 39.01 | -3.56% |
|
Netherlands |
|
2 |
USD 23.67 |
Jan. 14, 2025 | USD 23.67 | -3.70% |
|
Netherlands |
|
3 |
USD 16.00 |
Jan. 14, 2025 | USD 16.00 | -2.50% |
|
Netherlands |
|
4 |
USD 13.23 |
Jan. 14, 2025 | USD 13.23 | -4.06% |
|
Netherlands |
|
5 |
USD 2.26 |
Jan. 14, 2025 | USD 2.26 | -0.44% |
|
Netherlands |
|
6 |
USD 0.98 |
Jan. 14, 2025 | USD 0.98 | -1.01% |
|
Netherlands |
The Clinical Trials company in Netherlands with the highest Share Price is Merus N.V. (NasdaqGM: MRUS) at USD 39.01.
The Clinical Trials company in Netherlands with the lowest Share Price is LAVA Therapeutics N.V. (NasdaqGS: LVTX) at USD 0.98.
The top 10 Clinical Trials companies in Netherlands by Share Price are Merus N.V., NewAmsterdam Pharma Company N.V., Pharvaris N.V., uniQure N.V., ProQR Therapeutics N.V. and LAVA Therapeutics N.V..
The bottom 10 Clinical Trials companies in Netherlands by Share Price are LAVA Therapeutics N.V., ProQR Therapeutics N.V., uniQure N.V., Pharvaris N.V., NewAmsterdam Pharma Company N.V. and Merus N.V..